Endostatin attenuates PDGF-BB- or TGF-β1-induced HSCs activation via suppressing RhoA/ROCK1 signal pathways [Erratum]
Open Access
- 1 January 2019
- journal article
- correction
- Published by Taylor & Francis Ltd in Drug Design, Development and Therapy
- Vol. ume 13, 499-500
- https://doi.org/10.2147/dddt.s202671
Abstract
Endostatin attenuates PDGF-BB- or TGF-beta1-induced HSCs activation via suppressing RhoA/ROCK1 signal pathways [Erratum]This publication has 1 reference indexed in Scilit:
- Endostatin attenuates PDGF-BB- or TGF-β1-induced HSCs activation via suppressing RhoA/ROCK1 signal pathwaysDrug Design, Development and Therapy, 2019